Key result
Antiplatelet agents targeting platelet adhesion, activation, and aggregation provide protection against thrombotic events, though balancing antithrombotic efficacy and bleeding risk remains a challenge.
Design
Review
Authors
Loading...
Requires individualized risk-benefit assessment in antiplatelet use; leaves open optimization of targeted therapies pending prospective trials.
This review provides a comprehensive overview of current and emerging antiplatelet therapies targeting different stages of thrombus formation.
Jing Fang (2013) conducted a review in Thrombosis and thromboembolic disorders. Antiplatelet agents was evaluated. Antiplatelet agents targeting platelet adhesion, activation, and aggregation provide protection against thrombotic events, though balancing antithrombotic efficacy and bleeding risk remains a challenge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: